Plant-based MilkNCT07730229
Study the Effect of Plant-based Beverage Consumption on the Gut Microbiome in Healthy Adults
A study testing plant-based beverage in people with Plant-based Milk and Gastrointestinal Microbiome, run by Lund University at 1 site in Sweden.
Trial summary
The goal of this intervention study is to analyse the microbiota composition after the plant-based beverage consumption. The main questions are to evaluate if the plant-based beverage can have a beneficial effect on the gut microbiota. Read more about this study
- Who is it for?
- Ages 18 to 65 yearsHealthy volunteers can take part
- Conditions the study is for
- Plant-based Milk, Gastrointestinal Microbiome
- What is being tested?
- plant-based beverage
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 60 participants
- Where
- 1 siteSweden
- Study dates
- 10 Nov 2025to 31 Jul 2026
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 65 years
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- 18-65 years of age. • must be able to complete the form digitally.
Who cannot join
- Must not be diagnosed with gastrointestinal diseases, autoimmune diseases or have diseases or medications that cause immune deficiency, such as MS, type 1 diabetes, cancer or HIV
- must not take antibiotics during the study period
- must not have a milk protein allergy
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Sweden1 site, 1 recruiting
- Recruiting
Lund University
Lund, Skåne County, 22100
Åsa Håkansson, PhD, +46704566277, asa.hakansson@ple.lth.se
Rumathi de Mel, Masters, +46737464561, rumathi.de_mel@ple.lth.se
About this study
Official title: Analysis of the Intestinal Flora Composition After Consumption of Plant-based Beverages
The goal of this intervention study is to analyse the microbiota composition after the plant-based beverage consumption. The main questions are to evaluate if the plant-based beverage can have a beneficial effect on the gut microbiota. Participants will consume different plant-based beverages for two weeks, and microbiota will be analysed. Researchers will compare the microbiota composition before and after consumption.
- Conditions
- Plant-based Milk, Gastrointestinal Microbiome
- Being tested
- plant-based beverage
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
plant-based beverageDietary supplement
Participants will consume the assigned plant-based beverages for two weeks.
| Study group | Role | What they receive |
|---|---|---|
| Active group | Active comparator | Participants will consume the assigned dairy milk for two weeks. Receives: Dietary Supplement: plant-based beverage |
| Experimental group | Experimental | Participants will consume the assigned plant-based beverages for two weeks. Receives: Dietary Supplement: plant-based beverage |
What is being measured
The primary outcome is the main question the study is designed to answer.
Change in gut microbiome alpha diversity
Gut microbiome alpha diversity will be assessed using 16S rRNA gene sequencing and quantified using alpha diversity indices (e.g., Shannon diversity index).
Measured: up to 24 weeks
Change in gut microbiome beta diversity
Gut microbiome beta diversity will be assessed using 16S rRNA gene sequencing by comparing community composition between samples using beta diversity distance metrics (e.g., Bray-Curtis dissimilarity or UniFrac distances).
Measured: Upto 24 weeks
Secondary outcomes (1)
Change in the relative abundance of gut bacterial taxa
The relative abundance of bacterial taxa identified by 16S rRNA gene sequencing will be compared between study groups and over time.
Measured: Baseline to Week 24
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted28 Jul 2026
- Study start10 Nov 2025
- Primary completion30 Jul 2026 (estimated)
- Study completion31 Jul 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Plant-based MilkStudies of the same condition, open and under way.
- More trials run by Lund UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 60 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Lund University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Åsa Håkansson, Lund University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07730229
- Sponsor's protocol ID
- Plant-based beverages
- Status last verified
- Jul 2026
- First submitted
- 29 Jun 2026
- Last updated
- 28 Jul 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 28 Jul 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Analysis of the Intestinal Flora Composition After Consumption of Plant-based Beverages
- ClinicalTrials.gov ID
- NCT07730229
- Acronym / sponsor ID
- Plant-based beverages
- Conditions
- Plant-based Milk, Gastrointestinal Microbiome
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 60 participants (estimated)
- Lead sponsor
- Lund UniversityUniversity, hospital or other
- Study start
- 10 Nov 2025 (actual)
- Primary completion
- 30 Jul 2026 (estimated)
- Study completion
- 31 Jul 2026 (estimated)
- First posted
- 28 Jul 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The goal of this intervention study is to analyse the microbiota composition after the plant-based beverage consumption. The main questions are to evaluate if the plant-based beverage can have a beneficial effect on the gut microbiota. Participants will consume different plant-based beverages for two weeks, and microbiota will be analysed. Researchers will compare the microbiota composition before and after consumption.
Study design
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Active group | Active comparator | Dietary Supplement: plant-based beverageParticipants will consume the assigned dairy milk for two weeks. |
| Experimental group | Experimental | Dietary Supplement: plant-based beverageParticipants will consume the assigned plant-based beverages for two weeks. |
Who may qualify
- Ages
- 18 to 65 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (1 listed)
- 18-65 years of age. • must be able to complete the form digitally.
Key exclusion criteria (3 listed)
- Must not be diagnosed with gastrointestinal diseases, autoimmune diseases or have diseases or medications that cause immune deficiency, such as MS, type 1 diabetes, cancer or HIV
- must not take antibiotics during the study period
- must not have a milk protein allergy
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| plant-based beverageParticipants will consume the assigned plant-based beverages for two weeks. | Dietary supplement | Active group, Experimental group |
Primary outcome
Change in gut microbiome alpha diversity
Time frame: up to 24 weeks
Gut microbiome alpha diversity will be assessed using 16S rRNA gene sequencing and quantified using alpha diversity indices (e.g., Shannon diversity index).
Change in gut microbiome beta diversity
Time frame: Upto 24 weeks
Gut microbiome beta diversity will be assessed using 16S rRNA gene sequencing by comparing community composition between samples using beta diversity distance metrics (e.g., Bray-Curtis dissimilarity or UniFrac distances).
1 secondary outcome
Change in the relative abundance of gut bacterial taxa
Time frame: Baseline to Week 24
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 28 Jul 2026.
Related trials for Plant-based Milk
Recruiting
Maximising Maternal Milk for Preterm Infant
Breastfeeding, Prematurity
Not yet recruiting
Performance of the Basophil Activation Test in the Diagnosis of IgE-mediated Cow's Milk Allergy in Infants and Evaluation of Hydrolysate Allergenicity.
Milk Allergy
Recruiting
The Effect of Breast Milk, 10% and 20% Dextrose on Pain and Physiological Variables During Heel Puncture in Infants
Newborn Care, Pain Management
Not yet recruiting
Fermented Mare's Milk Supplementation During Acute Viral Respiratory Infection
Acute Respiratory Diseases
Active, not recruitingObservational study
A Study Evaluating the Presence and Concentration of BRIUMVI™ (Ublituximab) in Breast Milk
Relapsing Multiple Sclerosis
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing plant-based beverage in people with Plant-based Milk and Gastrointestinal Microbiome, run by Lund University at 1 site in Sweden.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 28 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Sweden. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Each site lists its own contact: choose the nearest one under Trial locations. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Change in gut microbiome alpha diversity (time frame: up to 24 weeks). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Jul 2026.